Drexel Morgan & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.87M | Hold |
21,546
| – | – | 0.27% | 37 |
|
|
2025
Q4 | $2.07M | Hold |
21,546
| – | – | 0.32% | 35 |
|
|
2025
Q3 | $2.05M | Hold |
21,546
| – | – | 0.32% | 32 |
|
|
2025
Q2 | $1.88M | Hold |
21,546
| – | – | 0.33% | 32 |
|
|
2025
Q1 | $1.94M | Hold |
21,546
| – | – | 0.41% | 30 |
|
|
2024
Q4 | $1.72M | Hold |
21,546
| – | – | 0.36% | 33 |
|
|
2024
Q3 | $1.94M | Hold |
21,546
| – | – | 0.36% | 32 |
|
|
2024
Q2 | $1.7M | Hold |
21,546
| – | – | 0.36% | 33 |
|
|
2024
Q1 | $1.88M | Buy |
21,546
+220
| +1% | +$18.8K | 0.39% | 30 |
|
|
2023
Q4 | $1.76M | Hold |
21,326
| – | – | 0.41% | 29 |
|
|
2023
Q3 | $1.67M | Buy |
21,326
+625
| +3% | +$52.3K | 0.45% | 28 |
|
|
2023
Q2 | $1.82M | Hold |
20,701
| – | – | 0.47% | 29 |
|
|
2023
Q1 | $1.67M | Hold |
20,701
| – | – | 0.42% | 30 |
|
|
2022
Q4 | $1.61M | Hold |
20,701
| – | – | 0.33% | 31 |
|
|
2022
Q3 | $1.67M | Buy |
20,701
+480
| +2% | +$43.1K | 0.4% | 30 |
|
|
2022
Q2 | $1.81M | Hold |
20,221
| – | – | 0.5% | 29 |
|
|
2022
Q1 | $2.24M | Hold |
20,221
| – | – | 0.65% | 24 |
|
|
2021
Q4 | $2.09M | Hold |
20,221
| – | – | 0.61% | 28 |
|
|
2021
Q3 | $2.54M | Hold |
20,221
| – | – | 0.81% | 23 |
|
|
2021
Q2 | $2.51M | Sell |
20,221
-683
| -3% | -$85.8K | 0.74% | 29 |
|
|
2021
Q1 | $2.47M | Sell |
20,904
-6
| -0% | -$703 | 0.63% | 34 |
|
|
2020
Q4 | $2.45M | Sell |
20,910
-90
| -0.4% | -$9.91K | 0.67% | 33 |
|
|
2020
Q3 | $2.18M | Buy |
21,000
+191
| +0.9% | +$19.2K | 0.77% | 34 |
|
|
2020
Q2 | $1.91M | Buy |
20,809
+73
| +0.4% | +$7K | 0.72% | 35 |
|
|
2020
Q1 | $1.87M | Buy |
20,736
+6,288
| +44% | +$669K | 0.72% | 32 |
|
|
2019
Q4 | $1.64M | Sell |
14,448
-3,775
| -21% | -$414K | 1.23% | 28 |
|
|
2019
Q3 | $1.98M | Sell |
18,223
-41
| -0.2% | -$4.28K | 1.53% | 25 |
|
|
2019
Q2 | $1.78M | Sell |
18,264
-55
| -0.3% | -$5.02K | 1.37% | 30 |
|
|
2019
Q1 | $1.67M | Buy |
18,319
+645
| +4% | +$57.7K | 1.48% | 30 |
|
|
2018
Q4 | $1.61M | Buy |
17,674
+572
| +3% | +$53.5K | 1.61% | 27 |
|
|
2018
Q3 | $1.68M | Buy |
17,102
+197
| +1% | +$18.2K | 1.48% | 30 |
|
|
2018
Q2 | $1.45M | Buy |
16,905
+968
| +6% | +$80.9K | 1.45% | 32 |
|
|
2018
Q1 | $1.28M | Buy |
15,937
+130
| +0.8% | +$10.7K | 1.33% | 33 |
|
|
2017
Q4 | $1.28M | Buy |
15,807
+273
| +2% | +$21.9K | 1.24% | 33 |
|
|
2017
Q3 | $1.21M | Sell |
15,534
-1,623
| -9% | -$135K | 1.24% | 34 |
|
|
2017
Q2 | $1.52M | Buy |
17,157
+218
| +1% | +$18.4K | 1.56% | 25 |
|
|
2017
Q1 | $1.36M | Buy |
16,939
+2,609
| +18% | +$204K | 1.51% | 25 |
|
|
2016
Q4 | $1.02M | Hold |
14,330
| – | – | 1.21% | 32 |
|
|
2016
Q3 | $1.24M | Hold |
14,330
| – | – | 1.37% | 27 |
|
|
2016
Q2 | $1.24M | Sell |
14,330
-34
| -0.2% | -$2.75K | 1.41% | 25 |
|
|
2016
Q1 | $1.08M | Buy |
14,364
+154
| +1% | +$11.6K | 1.26% | 31 |
|
|
2015
Q4 | $1.09M | Buy |
14,210
+132
| +0.9% | +$9.94K | 1.21% | 30 |
|
|
2015
Q3 | $943K | Sell |
14,078
-452
| -3% | -$33.3K | 1.22% | 30 |
|
|
2015
Q2 | $1.08M | Sell |
14,530
-2,084
| -13% | -$159K | 1.28% | 26 |
|
|
2015
Q1 | $1.3M | Buy |
16,614
+3,603
| +28% | +$273K | 1.38% | 19 |
|
|
2014
Q4 | $939K | Hold |
13,011
| – | – | 1.06% | 32 |
|
|
2014
Q3 | $806K | Sell |
13,011
-1
| -0% | -$64 | 0.98% | 35 |
|
|
2014
Q2 | $830K | Sell |
13,012
-4,561
| -26% | -$277K | 1% | 32 |
|
|
2014
Q1 | $1.08M | Buy |
17,573
+200
| +1% | +$11.7K | 1.37% | 22 |
|
|
2013
Q4 | $997K | Buy |
17,373
+694
| +4% | +$39.4K | 1.34% | 23 |
|
|
2013
Q3 | $888K | Buy |
16,679
+7,417
| +80% | +$399K | 1.22% | 27 |
|
|
2013
Q2 | $477K | Buy |
+9,262
| New | +$458K | 0.79% | 36 |
|
Other funds holding MDT
VCM
VPM
Drexel Morgan & Co's MDT Position: Q1 2026 in Review
Drexel Morgan & Co held its Medtronic (MDT) position steady in Q1 2026 at 21,546 shares worth $1.87M. The position accounts for 0.27% of the portfolio, ranked #37.
Drexel Morgan & Co first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.54M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Drexel Morgan & Co held 21,546 shares of Medtronic worth $1.87M as of Q1 2026.
- Drexel Morgan & Co left its Medtronic share count unchanged in Q1 2026.
- Medtronic made up 0.27% of Drexel Morgan & Co's portfolio in Q1 2026, its #37 holding.
- Drexel Morgan & Co first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Drexel Morgan & Co's Medtronic position peaked at $2.54M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.